ATE77751T1 - Mittel zur behandlung von knochenkrankheiten. - Google Patents

Mittel zur behandlung von knochenkrankheiten.

Info

Publication number
ATE77751T1
ATE77751T1 AT86105921T AT86105921T ATE77751T1 AT E77751 T1 ATE77751 T1 AT E77751T1 AT 86105921 T AT86105921 T AT 86105921T AT 86105921 T AT86105921 T AT 86105921T AT E77751 T1 ATE77751 T1 AT E77751T1
Authority
AT
Austria
Prior art keywords
bone
treatment
bone diseases
calcium
resorption
Prior art date
Application number
AT86105921T
Other languages
English (en)
Inventor
Richard S Bockman
Raymond P Warrell Jr
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/729,057 external-priority patent/US4704277A/en
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of ATE77751T1 publication Critical patent/ATE77751T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT86105921T 1985-04-30 1986-04-29 Mittel zur behandlung von knochenkrankheiten. ATE77751T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/729,057 US4704277A (en) 1985-04-30 1985-04-30 Methods of treating bone disorders
US06/853,144 US4686104A (en) 1985-04-30 1986-04-22 Methods of treating bone disorders
EP86105921A EP0201804B1 (de) 1985-04-30 1986-04-29 Mittel zur Behandlung von Knochenkrankheiten

Publications (1)

Publication Number Publication Date
ATE77751T1 true ATE77751T1 (de) 1992-07-15

Family

ID=27111805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86105921T ATE77751T1 (de) 1985-04-30 1986-04-29 Mittel zur behandlung von knochenkrankheiten.

Country Status (5)

Country Link
US (1) US4686104A (de)
EP (1) EP0201804B1 (de)
AT (1) ATE77751T1 (de)
CA (1) CA1277598C (de)
DE (1) DE3685853T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4976971A (en) * 1983-03-14 1990-12-11 Ethyl Corporation Zeolites in poultry nutrition
US4556564A (en) * 1983-03-14 1985-12-03 Ethyl Corporation Feeding of zeolite A to poultry
EP0367787B2 (de) * 1987-06-30 1999-01-27 Mallinckrodt, Inc. (a Delaware corporation) Verfahren zur erhöhung der sicherheit von metall-ligandchelaten als röntgenstrahlen-kontrastmittel
US4911931A (en) * 1987-08-03 1990-03-27 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
US5252345A (en) * 1988-02-08 1993-10-12 Ethyl Corporation Zeolite compositions
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
US5556645A (en) * 1990-01-12 1996-09-17 Bockman; Richard Methods of enhancing wound healing and tissue repair
US5686116A (en) * 1990-01-12 1997-11-11 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Methods of enhancing repair, healing and augmentation of bone implants
US5071655A (en) * 1990-01-12 1991-12-10 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US5763480A (en) * 1994-02-14 1998-06-09 The Jewish Hospital Of St. Louis Inhibitors of cell-medicated disorders
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
US5843936A (en) * 1996-06-28 1998-12-01 Bernstein; Lawrence R. Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
HK1049787B (en) 1999-10-01 2014-07-25 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2007061783A1 (en) * 2005-11-18 2007-05-31 Trustees Of Boston University Treatment and prevention of bone loss using resolvins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004003A (en) * 1974-08-28 1977-01-18 The Upjohn Company 25-Hydroxycalciferol compounds for treatment of steroid-induced osteoporosis
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
FR2500303A1 (fr) * 1981-02-20 1982-08-27 Meram Lab Le chlorure de gallium, nouveau medicament anti-cancereux
EP0109564B1 (de) * 1982-10-22 1988-04-27 Sloan-Kettering Institute For Cancer Research Verwendung von Gallium-Salzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Störungen der Calcium-Homöostasis

Also Published As

Publication number Publication date
DE3685853T2 (de) 1992-12-24
DE3685853D1 (de) 1992-08-06
CA1277598C (en) 1990-12-11
EP0201804B1 (de) 1992-07-01
US4686104A (en) 1987-08-11
EP0201804A1 (de) 1986-11-20

Similar Documents

Publication Publication Date Title
ATE77751T1 (de) Mittel zur behandlung von knochenkrankheiten.
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
NO20002005L (no) FremgangsmÕte for behandling av hyperkoagulable tilstander eller protein C mangel
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
SE8501050D0 (sv) Biologically active fragments of human antihemophilic factor and method for preparation thereof
ATE257378T1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
EP0376251A3 (en) An anticoagulant substance obtained from urine
EP0315591A3 (en) Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them
DE59508961D1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DE59605959D1 (de) Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
ATE88633T1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE60108130D1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
DE60042171D1 (de) Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
DE69223455D1 (de) WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
FR2635006B1 (fr) Medicament destine a regulariser les secretions hormonales et a traiter la sterilite
ATE81587T1 (de) Medizinisches praeparat zur behandlung von hautleiden.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee